Alteration of Phospholipase C‐δ Protein Level and Specific Activity in Alzheimer's Disease

Abstract: Phosphoinositide‐specific phospholipase C (PLC) is a key enzyme in signal transduction. We have previously demonstrated that an antibody to an isozyme of PLC, PLC‐δ, produced intense staining of neurofibrillary tangles in the brains of patients with Alzheimer's disease. In the present study, we investigated the protein level and activity of this enzyme in control and Alzheimer brains. Western blot analysis using a specific antibody for PLC‐δ showed that the concentration of PLC‐δ protein was significantly higher in the cytosolic fraction of Alzheimer's disease cortical tissue than in control brains. The activity of PLC‐δ, which hydrolyzes phosphatidylinositol, was also investigated, and we found that PLC‐δ activity was not significantly different in the Alzheimer and control cytosolic fractions. These results indicate that the specific activity of PLC‐δ is decreased in Alzheimer brains and suggest that inactivation of PLC‐δ might be related to the pathophysiology of this disease.

[1]  S. Shimohama,et al.  Abnormal accumulation of phospholipase C-δ in filamentous inclusions of human neurodegenerative diseases , 1993, Neuroscience Letters.

[2]  T. Taniguchi,et al.  Aberrant Phosphoinositide Metabolism in Alzheimer's Disease a , 1993, Annals of the New York Academy of Sciences.

[3]  A. Heyman,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part III. Reliability of a standardized MRI evaluation of Alzheimer's disease , 1992, Neurology.

[4]  T. Taniguchi,et al.  Phosphatidylinositol-specific phospholipase C activity in the postmortem human brain: no alteration in Alzheimer's disease , 1992, Brain Research.

[5]  F. Shibasaki,et al.  Enhancement of phospholipase C delta 1 activity in the aortas of spontaneously hypertensive rats. , 1992, The Journal of biological chemistry.

[6]  Y. Nonomura,et al.  Effects of gelsolin on human platelet cytosolic phosphoinositide-phospholipase C isozymes. , 1992, The Journal of biological chemistry.

[7]  T. Taniguchi,et al.  Aberrant accumulation of phospholipase C-delta in Alzheimer brains. , 1991, The American journal of pathology.

[8]  J. Blank,et al.  Purification, Properties, and Phosphorylation by Protein Kinase C of Two Phosphoinositidase C Isozymes from Rat Brain , 1991, Journal of neurochemistry.

[9]  A. Delacourte,et al.  Neuronal-specific expression of human copper-zinc superoxide dismutase gene in transgenic mice: animal model of gene dosage effects in Down's syndrome , 1991, Brain Research.

[10]  J. Backon.  Dementia in cancer patients undergoing chemotherapy: implication of free radical injury and relevance to Alzheimer disease. , 1991, Medical hypotheses.

[11]  P. Crino,et al.  Involvement of free radicals in dementia of the Alzheimer type: A hypothesis , 1990, Neurobiology of Aging.

[12]  A. Dalton,et al.  Red cell superoxide dismutase, glutathione peroxidase and catalase in Down syndrome patients with and without manifestations of Alzheimer disease. , 1990, American journal of medical genetics.

[13]  S. Y. Lee,et al.  Studies of inositol phospholipid-specific phospholipase C. , 1989, Science.

[14]  Y. Ihara.  Massive somatodendritic sprouting of cortical neurons in Alzheimer's disease , 1988, Brain Research.

[15]  Y. Nishizuka,et al.  The molecular heterogeneity of protein kinase C and its implications for cellular regulation , 1988, Nature.

[16]  S. Ryu,et al.  Cloning and sequence of multiple forms of phospholipase C , 1988, Cell.

[17]  S. Love,et al.  Alz-50, Ubiquitin and Tau Immunoreactivity of Neurofibrillary Tangles, Pick Bodies and Lewy Bodies , 1988, Journal of neuropathology and experimental neurology.

[18]  T. Kato,et al.  Neurofibrillary tangle formation in the nucleus basalis of meynert ipsilateral to a massive cerebral infarct , 1988, Annals of neurology.

[19]  P. Majerus,et al.  The metabolism of phosphoinositide-derived messenger molecules. , 1986, Science.

[20]  Michael J. Berridge,et al.  Inositol trisphosphate, a novel second messenger in cellular signal transduction , 1984, Nature.

[21]  P. Mckeever,et al.  A human ganglioglioma containing paired helical filaments. , 1984, Human pathology.

[22]  R. DeTeresa,et al.  Some morphometric aspects of the brain in senile dementia of the alzheimer type , 1981, Annals of neurology.

[23]  H. Wiśniewski,et al.  Alzheimer neurofibrillary tangles in diseases other than senile and presenile dementia , 1979, Annals of neurology.

[24]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[25]  勝谷 友宏.  Hypotensive effect associated with a phospholipase C-δ1 gene mutation in the spontaneously hypertensive rat , 1993 .

[26]  J. Klinowski,et al.  Oxidative damage in Alzheimer's dementia, and the potential etiopathogenic role of aluminosilicates, microglia and micronutrient interactions. , 1992, EXS.

[27]  M. Somerville,et al.  Localization and quantitation of 68 kDa neurofilament and superoxide dismutase-1 mRNA in Alzheimer brains. , 1991, Brain research. Molecular brain research.